PIK3CA and gastric cancer: Moreover, molecularly targeted therapies against PI3K and the TGF-β axis may be candidates for treatment of advanced GSC, although therapeutic strategies for targeting mutations in PTEN and SMAD4 have not been established for gastric cancer.